DE2263110C3 - - Google Patents

Info

Publication number
DE2263110C3
DE2263110C3 DE19722263110 DE2263110A DE2263110C3 DE 2263110 C3 DE2263110 C3 DE 2263110C3 DE 19722263110 DE19722263110 DE 19722263110 DE 2263110 A DE2263110 A DE 2263110A DE 2263110 C3 DE2263110 C3 DE 2263110C3
Authority
DE
Germany
Prior art keywords
acid
mol
melting point
triazine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19722263110
Other languages
German (de)
English (en)
Other versions
DE2263110B2 (de
DE2263110A1 (de
Inventor
Gunter Dr. 7902 Blaubeuren Metz
Manfred Dr. 7930 Ehingen Specker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Merckle GmbH and Co KG Chem Pharm Fabrik
Original Assignee
Ludwig Merckle GmbH and Co KG Chem Pharm Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Merckle GmbH and Co KG Chem Pharm Fabrik filed Critical Ludwig Merckle GmbH and Co KG Chem Pharm Fabrik
Priority to DE19722263110 priority Critical patent/DE2263110B2/de
Priority to AT1076673A priority patent/AT328459B/de
Priority to CH1809673A priority patent/CH598235A5/xx
Priority to GB5983473A priority patent/GB1384684A/en
Publication of DE2263110A1 publication Critical patent/DE2263110A1/de
Publication of DE2263110B2 publication Critical patent/DE2263110B2/de
Application granted granted Critical
Publication of DE2263110C3 publication Critical patent/DE2263110C3/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19722263110 1972-12-22 1972-12-22 2-Amino-4-phenyläthylamino-6-phenoxymethyl-1 ^-triazine und Verfahren zu ihrer Herstellung Granted DE2263110B2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19722263110 DE2263110B2 (de) 1972-12-22 1972-12-22 2-Amino-4-phenyläthylamino-6-phenoxymethyl-1 ^-triazine und Verfahren zu ihrer Herstellung
AT1076673A AT328459B (de) 1972-12-22 1973-12-21 Verfahren zur herstellung von neuen 1,3,5-triazinen
CH1809673A CH598235A5 (xx) 1972-12-22 1973-12-21
GB5983473A GB1384684A (en) 1972-12-22 1973-12-27 1,3,5-triazine and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722263110 DE2263110B2 (de) 1972-12-22 1972-12-22 2-Amino-4-phenyläthylamino-6-phenoxymethyl-1 ^-triazine und Verfahren zu ihrer Herstellung

Publications (3)

Publication Number Publication Date
DE2263110A1 DE2263110A1 (de) 1974-07-11
DE2263110B2 DE2263110B2 (de) 1980-01-31
DE2263110C3 true DE2263110C3 (xx) 1980-09-18

Family

ID=5865287

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722263110 Granted DE2263110B2 (de) 1972-12-22 1972-12-22 2-Amino-4-phenyläthylamino-6-phenoxymethyl-1 ^-triazine und Verfahren zu ihrer Herstellung

Country Status (4)

Country Link
AT (1) AT328459B (xx)
CH (1) CH598235A5 (xx)
DE (1) DE2263110B2 (xx)
GB (1) GB1384684A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3950802A (en) * 2000-12-07 2002-06-18 Cv Therapeutics Inc Abca-1 elevating compounds
US20060004005A1 (en) * 2003-09-25 2006-01-05 Sattigeri Viswajanani J Triazines derivatives as cell adhesion inhibitors
JP5491871B2 (ja) * 2007-02-28 2014-05-14 アドビナス セラピュティックス プライベート リミテッド グルコキナーゼ活性化因子としての２，２，２−三置換アセトアミド誘導体、その方法及び薬学的応用

Also Published As

Publication number Publication date
AT328459B (de) 1976-03-25
DE2263110B2 (de) 1980-01-31
CH598235A5 (xx) 1978-04-28
GB1384684A (en) 1975-02-19
ATA1076673A (de) 1975-06-15
DE2263110A1 (de) 1974-07-11

Similar Documents

Publication Publication Date Title
DE2904552A1 (de) 1,4-dihydropyridin-3,5-dicarbonsaeureesterderivate, verfahren zu ihrer herstellung
DE1645971C3 (de) (lndazol-3-yl)-oxyessigsäurederivate, Verfahren zu ihrer Herstellung und Mittel mit entzündungshemmender Wirkung
DE3412885A1 (de) Fuoro-(3,4-c)-pyridin-derivate, verfahren zu ihrer herstellung und arzneimittel
DE2311570C2 (de) 4-Aminochinoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2716837A1 (de) Adenin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2263110C3 (xx)
DE2631885A1 (de) Phenoxyderivate, verfahren zu ihrer herstellung und deren therapeutische verwendung
DE1967080C3 (de) t-(3,4-Methylendioxybeiizoyl)-2methyl-5-methoxy-3-indolylessigsäureester, Verfahren zu ihrer Herstellung und Arzneipräparate
DE2157272A1 (de) Arzneimittel und Verfahren zur Herstellung von insbesondere als Wirkstoff für diese brauchbarem bis-(p-Chlorphenoxy)acetylhamstoff
DE1965711B2 (de) l^-Dihydro-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2912026C2 (xx)
DE2403786A1 (de) Neue derivate der cumarine
DE1957769C3 (de) 4,6-Diamino-l,2-dihydro-2,2-dimethyl-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE2309087A1 (de) Amidoimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE1795384C3 (de) 1 H-2,3-Benzoxazine, Verfahren zu deren Herstellung sowie Arzneimittel
EP0049494B1 (de) Ester von 7-Hydroxylalkyl-1,3-dimethylxanthinen, Verfahren zu ihrer Herstellung und ihre Verwendung als lipidsenkende Mittel
DE2520483A1 (de) Phenoxy-isobuttersaeurederivate und diese verbindungen enthaltende arzneimittel
DE1620124C3 (de) 8-Hydroxychinolinderivate
DE2624856A1 (de) 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
DE2536170B2 (xx)
DE2238304A1 (de) Choleretisch wirksame ester bzw. salze von gallensaeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2628642C2 (de) In 2-Stellung substituierte 1,3-Diaza-fünfringkohlenstoffverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE2435248A1 (de) 1,3-diamino-2-propanole, ein verfahren zu deren herstellung und ein dieselben enthaltendes mittel
DE2502679C3 (de) Phenoxyalkancarbonsäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel
DE2506256C2 (de) 5-Nitro-imidazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee